Symbols / SRTS

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Price estimates from analyst targets and simple models.

Latest analyst rating changes

• Sensus Healthcare Stock (SRTS) Opinions on Insider Buying and Strategic Updates | SRTS Stock News - Quiver Quantitative Wed, 19 Nov 2025 08
• New Sensus plan lets skin cancer clinics break even with 1 patient a month - Stock Titan Wed, 18 Feb 2026 13
• Sensus Healthcare (NASDAQ:SRTS) shareholders have endured a 36% loss from investing in the stock three years ago - Yahoo Finance hu, 12 Feb 2026 08
• Sensus Healthcare (NASDAQ:SRTS) stock falls 38% in past week as three-year earnings and shareholder returns continue downward trend - simplywall.st Sat, 09 Aug 2025 07
• Electronic Arts Stock Is Up in 2026. Here’s What Strong Q3 Results Mean for the Next Two Years - TIKR.com Mon, 09 Feb 2026 08
• Why Genius Sports Stock Just Crashed Today - The Motley Fool hu, 05 Feb 2026 08
• SRTS: Maxim Group Lowers Price Target, Maintains Buy Rating | SR - GuruFocus ue, 17 Feb 2026 08
• $SRTS stock is down 20% today. Here's what we see in our data. - Quiver Quantitative Fri, 13 Feb 2026 19
• Electronic Arts stock closes up 15% on report company near $50 billion deal to go private - CNBC Fri, 26 Sep 2025 07
• Electronic Arts Stock Jumps On Reported Go-Private Deal - Investor's Business Daily Fri, 26 Sep 2025 07
• Earnings call and business update from Sensus Healthcare set for Feb. 12 - Stock Titan hu, 05 Feb 2026 08
• Are Wall Street Analysts Bullish on Electronic Arts Stock? - Yahoo Finance hu, 12 Feb 2026 08
• Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Share Price Boosted 38% But Its Business Prospects Need A Lift Too - simplywall.st Wed, 14 Jan 2026 08
• GE imaging leader joins board of non-invasive skin treatment firm - Stock Titan Wed, 07 Jan 2026 08
• $SRTS stock is up 11% today. Here's what we see in our data. - Quiver Quantitative ue, 04 Nov 2025 08

• Income Statement
• Balance Sheet
• Cash Flow

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

• 8-K2026-02-12 View
• 8-K2026-01-20 View
• 8-K2026-01-12 View
• 42025-12-16 View
• 42025-11-21 View
• 42025-11-20 View
• 42025-11-19 View
• 42025-11-19 View
• 8-K2025-11-13 View
• 10-Q2025-11-12 View
• 42025-11-12 View
• 8-K2025-11-06 View
• 42025-08-14 View
• 10-Q2025-08-12 View
• 8-K2025-08-07 View